MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Co-existence of Myasthenia Gravis and Parkinson’s disease, plus essential tremor in a veteran at Camp Lejeune

    Y. Kim, K. Colletta (Maywood, USA)

    Objective: We report a unique case of a patient with concurrent myasthenia gravis and Parkinson’s disease, with a history of environmental exposure to organic solvents…
  • 2025 International Congress

    Associations between Inflammation and Sleep Quality in Parkinson’s Disease: Exploring the Potential Influence of Sex.

    J. Cristini, V. Daneault, F. Seo, A. Bon, A. Potvin-Desrochers, J. Mustafa, L. Rodrigues, A. Dagher, R. Postuma, P. Rosa-Neto, J. Carrier, A. Amara, S. Steib, C. Paquette, M. Roig (Montreal, Canada)

    Objective: To investigate associations between inflammatory blood markers and sleep quality in Parkinson’s Disease (PD) and explore whether biological sex influences these associations. Background: Inflammation…
  • 2025 International Congress

    Automatic Intelligibility Rating in Parkinson’s Disease: A Multilingual Approach

    T. Thies, F. Dörr, A. König, N. Linz, M. Barbe, J. Orozco-Arroyave, J. Rusz, J. Tröger (Saarbrücken, Germany)

    Objective: To investigate the validity and robustness of an automatically generated intelligibility score in Parkinson’s disease (PD) across multiple languages. Background: 90% of people with…
  • 2025 International Congress

    Traditional Deep Brain Stimulation Programming versus Automated Image-Guided Algorithm in Patients with Parkinson’s Disease

    H. Maghzi, C. Kim, S. Worthge, C. Malatt, M. Tagliati (Los Angeles, USA)

    Objective: To compare traditional initial deep brain stimulation (DBS) programming with artificial intelligence (AI)-assisted automated image-guided DBS programming algorithm. Background: DBS programming is a complex,…
  • 2025 International Congress

    Electrochemical Sensing for Accurate L-Dopa Detection in Parkinson’s disease

    P. Dutta, A. Eshore, P. Guha, M. Acharya (Kharagpur, India)

    Objective: This study aims to develop a cost-effective, portable electrochemical sensor for real-time L-dopa monitoring in PD patients, addressing the limitations of current detection techniques.…
  • 2025 International Congress

    Expanding the Scope Beyond Neurosurgery: A Systematic Review on MRgFUS Complications

    K. Heintzelman, D. Fletcher, J. Melott, K. Gelman, B. Mendelson, A. Memon (Morgantown, USA)

    Objective: This systematic review aims to investigate the complications associated with MRgFUS (magnetic resonance-guided high intensity focused ultrasound) for neurological disorders and determine their frequency…
  • 2025 International Congress

    Clinical Features Suggestive of Alpha-Synucleinopathy in Progressive Supranuclear Palsy

    C. Painous, A. Martínez-Reyes, J. Santamaria, M. Fernández, A. Cámara, Y. Compta (Barcelona, Spain)

    Objective: To compare the presence of symptoms suggestive of synucleinopathy between PSP-parkinsonism (PSP-P), Parkinson's disease (PD) and PSP-Richardson syndrome (PSP-RS). Background: Clinical signs with high…
  • 2025 International Congress

    A Multidomain Fall Prevention Program: Perspectives of People with Parkinson’s Disease and their Care Partners

    L. Goh, A. Darmali, C. Koch, S. Tran, S. Paul, C. Canning, S. Edwards, S. Harkness, R. Savage, L. Webster, G. Zelma, N. Allen (Camperdown, Australia)

    Objective: To explore the acceptability of a multidomain fall prevention program (Integrate) for people with Parkinson’s disease (PwP) and their care-partners, and factors that influenced…
  • 2025 International Congress

    Tumeric and Curcumin Improve Motor Function and Reduce Catalepsy in a Rotenone -Induced Parkinson’s Disease Model

    L. Darbinyan, L. Hambardzumyan, K. Simonyan, V. Sarkisian, L. Manukyan (Yerevan, Armenia)

    Objective: Catalepsy measurements play a crucial role in behavioral research on Parkinson’s disease (PD), as they reflect significant motor impairments associated with dopaminergic dysfunction. In…
  • 2025 International Congress

    Enhancing Sleep in Parkinson’s Disease: A Retrospective Study on Group CBT-I

    N. Hellmers, A. Weiss, D. Zhang, P. Glovinsky, D. Barone, A. Yoo, H. Ooi, H. Sarva (New York, USA)

    Objective: Weill Cornell Sleep Center and our movement disorder team developed a treatment program for individuals with Parkinson’s Disease (PD) with sleep disturbances. The goal…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #23559 (not found)
  • #24483 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley